Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.

Bioimmunate60 enrolled

Overview

Multiple sclerosis (MS) is a chronic progressive neurological autoimmune disease, that gradually affects patient's quality of life. There are about 2.5 millions patients world wide, with an increasing cost Burdon. Up to date, it remains unclear who are the exact cells to initiate the disease. During the disease, the repertoire of cells expands and undergoes changes. The purpose of this study is to characterize those changes.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Multiple Sclerosis

Interventions

Blood SamplingOTHER

Blood samples will be taken from all patients and healthy volunteers.

CSF SamplingOTHER

CSF sample will be taken from hospitalized newly diagnosed patients only.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with diagnosis of MS according to the revised criteria of McDonald or healthy volunteers * Ability to provide written informed consent. Exclusion Criteria: \- Active malignant disease

Locations (1)

Hadassah Medical Center

Jerusalem, Israel

RECRUITING

Outcomes

Primary Outcomes

Quantification of disease related white blood cells from blood and/ or CSF

Time frame: through study completion, an average of 6 months

Central Contacts

Sigalit Carmel, MD, MSc

CONTACT

+97225649302 sigalit@bioimmunate.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.